walks you through: What dose-response curves are and why they’re indispensable How curve-fitting models can Ready to grasp how a curve can mislead—or enlighten?

signaling  (also called functional selectivity), means that two molecules targeting the same receptor can Achieving that objective demands assays that can actually see the difference.  A single GPCR can stabilize multiple active conformations, each of which preferentially couples to a , PAMs and NAMs), and crucially, can do so in a pathway-selective manner. Allosteric modulators, which do not compete directly at the orthosteric site, can be missed entirely

Work on receptors such as GLP-1R and MC4R has demonstrated that internalized GPCRs can continue to signal agonist-induced conformational change to leave the cell surface — it requires an active state, and antagonists can At the MC4 receptor, alpha-MSH–driven responses can be washed off and antagonized by AgRP — these are BRET-based assays can quantify beta-arrestin recruitment and, depending on the assay design, distinguish Experimentally, this steady state between recycling and degradation can be dissected by blocking one

Every day spent misunderstanding the meaning of apparent affinity differences can slow your project’s But as Terry Kenakin reveals, this interpretation can be misleading, and sticking with it could slow doesn’t necessarily reflect what’s happening in a physiological context, and misunderstanding this can Misunderstandings at this level can delay optimization cycles, result in wasted SAR iterations, or cause

Kenakin reveals how two compounds tested in different systems can appear to differ by thousands-fold across full and partial agonists Preserves system independence When handled correctly, partial agonists can Delta–delta comparisons can be repeated, generating: Standard errors 95% confidence intervals And this Each pathway can produce a different apparent selectivity profile. But during discovery, pathway dissection can clarify mechanism and reveal hidden liabilities.

You can say what the drug “seems” to do, but not what it will do elsewhere. Models are the bridge. They take descriptive data from one system and translate it into parameters that can be applied to others Here’s the uncomfortable truth: you can never prove a model “right.” But you can build confidence through iteration. Garbage In, Garbage Out Even the best models can only work with the data they’re fed.

A well-behaved molecule in a dish can fail spectacularly in vivo, leaving teams with years of sunk costs Modern real-time assays can deliver these insights earlier, faster, and cheaper than most teams assume Allosteric antibodies can mirror or exceed small molecule complexity. Early cross-screening can flag biased phenotypes long before animal studies. Monthly AMAs  where you can challenge Dr. Kenakin with your own enzyme or GPCR interaction puzzles.

In this protected environment, pharmacokinetics can decouple from plasma clearance. When a drug rebounds after dissociating—something only possible in a diffusion-limited space—it can maintain New Tools for Getting Drugs Inside Cells All of this hinges on a simple question: can your compound get And while orthosteric ligands may never reach them, properly designed intracellular drugs can. Only in Terry’s Corner   Why Terry’s Corner In a world where GPCR science moves faster than most teams can

learn why calcium signals are inherently transient—giving rise to a “hemi-equilibrium” window that can Through real-world examples (like 5-HT2A and CCR5 agonists), Terry shows how slow-onset agonists can

It is also one of the most structurally demanding targets a discovery team can take on, because the amylin does not reliably predict its activity at AMY2 or AMY3, and a molecule's selectivity across the set can Two compounds matched on potency can still differ in signaling bias, the degree to which each drives A ligand that favors cAMP over β-arrestin, or the reverse, can produce a meaningfully different functional What amylin receptor signaling looks like when you can measure it Resolving this used to mean assembling

The idea is elegant: GLP-1 agonists drive rapid weight loss but can take muscle along with the fat, and It is a timely look at how receptor pharmacology can sharpen one of the most talked-about therapeutic room where he breaks down receptor pharmacology, functional selectivity, and ligand bias in ways you can You can also sign up for the free weekly Kenakin brief delivered to your inbox at https://www.ecosystem.drgpcr.com

Kenakin attributes this to limited cooperativity: the allosteric ligand can only shift receptor affinity Variations in receptor coupling partners can alter observed binding outcomes. Kenakin’s case studies demonstrate that these observations can be reconciled within structured models What Members Say “I think Terry’s Corner is a fantastic resource that can benefit any pharmacologist Kenakin, monthly AMAs where specific data can be interrogated, and an on-demand library built around

You can have the most brilliant minds and cutting-edge assays, but if your science isn't continuously integrated with your GPCR operational strategy and investment goals, even the most promising program can I understand that embracing a systematic approach can feel daunting, especially with the pressure to Brainstorm Officer, Attila Foris , is building a system so transparent that anyone joining the company can the momentum your GPCR program needs. 👉 https://calendly.com/drgpcr/yamina-corner Or explore how we can

A GPCR program can have world-class science, top-tier talent, and millions in funding — and still fail Every two-week delay in a DMTA cycle can burn through hundreds of thousands in salaries and overhead. discovery data management  pipeline, teams waste hours cleaning, reconciling, and integrating before they can the momentum your GPCR program needs. 👉 https://calendly.com/drgpcr/yamina-corner Or explore how we can

.” — Tom Sakmar A Use Case for Every Angle Beyond RAMPs, this platform can study: Scaffold protein interactions Kotliar sums it up best: “We went from one receptor to many… and now, from many, we can go back to one

In early-stage drug discovery, one miscalculated liability can bring an otherwise promising scaffold Highly selective filters can streamline resource allocation Early elimination of unsafe scaffolds prevents Metabolites and Irreversible Damage Formation of reactive metabolites that alkylate proteins or nucleic acids can Kenakin details how discovery teams can leverage atypical conditions to elucidate liabilities and satisfy

No more guesswork, only decisions you can trust. Scatter can masquerade as signal. Subtle shifts vanish in noise. Instead of relying on debate—or worse, intuition—you can calculate an F-value that objectively shows It gives you the power to compare slopes and elevations statistically—so you can confirm whether your lectures  that sharpen the tools you actually use in discovery A growing on-demand library  of lessons you can

receptor environments  amplifies target occupancy, even post-clearance ✅ Insight into why half-life can Drugs with poor pharmacokinetics can outperform flashier compounds by exploiting kinetic environments Why Half-Life Can Lie to You Most teams use systemic half-life as a proxy for action. Only in Terry’s Corner Why Terry’s Corner In a world where drug discovery is evolving faster than most can

Schild analysis remains one of the few conceptual anchors that can tell us when “simple” truly is simple—and No reduction  in the maximal response (the receptor can still be fully activated). Curvature  can signify heterogeneous receptors  or mixed response mechanisms. It can uncover what’s really  happening inside a complex system. Schild analysis remains the simplest, most revealing conversation we can have with biology.

This technique can acquire three-dimensional image stacks, facilitating the reconstruction of GPCR distribution This enzyme has been modified so a small molecule will covalently bind to it, which can in turn be attached They can be combined with other ligands and are very interesting in TR-FRET (Time-Resolved Förster Energy It can even study the GPCR distribution within endocytic vesicles and across subcellular compartments

In the realm of molecular research, precise interpretation is crucial; a misread curve can lead to lost exposes why traditional displacement logic breaks down in allosteric systems, and how overlooking this can Avoid costly blind spots:  Discover how G protein stoichiometry can dictate whether your assay informs—or Sharpen your discovery decisions ➤ Yamina’s Corner - The Hidden Cost of Busy A GPCR program can collapse—not

donors used in this technique have longer half-lives  than other fluorophores (between 300μs–1 ms) and can Quite often, there is a need to amplify the signal  strength to detect them, which can be achieved by They can be combined with second generation acceptors like d2, as well as brighter donors, further increasing It can also be combined with  multiplexing . By using donor-acceptor pairs with different emission spectra that don’t overlap, researchers can design

Welcome back GPCR lovers, In pharmacology, the wrong interpretation of antagonist behavior can derail Solve the problem of misinterpreting your data by understanding how slow-offset kinetics can mimic classical Avoid the professional threat of flawed data interpretations that can lead to costly dead ends and missed Breakthroughs, Not Breakdowns In the fast-paced world of GPCR drug discovery, the "go fast" mindset can Our content is meticulously vetted and organized to provide clarity and actionable insights that you can

These changes can alter how the receptor talks to G proteins, arrestins, or other receptors. this lecture is how cryptic binding pockets —sites that only exist briefly in certain receptor states—can candidates Underestimation of in vivo potency Kenakin explains why recognizing this phenomenon early can Outdated models can mislead your team, waste your resources, and cost your pipeline months of progress

Hi GPCR Community, If you work on GPCR discovery, you already know: early signals can mislead, and timing Right) Early discovery often serves you overlapping curves and noisy baselines; different mechanisms can Get an answer you can defend. Corner Today ➤ Celtarys Research – Confocal Imaging That Preserves GPCR Function Confocal imaging can Physiological relevance:  Fluorescent ligands can retain receptor integrity—critical when signaling readouts

With street-level contamination rising faster than medicine can adapt, Catherine’s work shows why overdose Why Oxygen Monitors Can Miss the Danger Perhaps the most unsettling part of Catherine’s work is the disconnect doesn’t fail in a single, predictable way—it collapses through overlapping pathways that no single drug can And the illicit supply is moving faster than clinical medicine can adjust. The question now is whether science and public health can keep up.”

Even minor adjustments can compromise photophysical properties. The outcome is not just a probe; it’s a tool scientists can trust. Whether in industry or academia, whether overexpressing or not, you can adapt the assay to your system Build or adopt assays that can evolve with your questions—like pHSense.” What’s Next?

Here you can find the full program . Figure 1. UIC Student Center East. you forget the importance GPCRs holds in drug development as a whole, and how each and every finding can Now back in Europe, all she can think about is next year’s date, in Dublin, where she is sure she will

conformations, and the binding of a ligand, as well as interactions with signaling molecules like G proteins, can Natural and synthetic ligands can be categorized into four distinct efficacy classes: 1) full agonists produce the maximal response and can differ in intrinsic efficacy; 2) partial agonists are incapable neutral antagonists have null intrinsic efficacy, thus not affecting receptor signaling activity, and can Moreover, they have the potential to enhance target selectivity, which can arise from greater sequence

These sites act as molecular switches that can modulate receptor activity, providing an untapped opportunity Allosteric ligands can be classified as positive allosteric modulators (PAMs), which increase the receptor Alternatively, they can function as neutral allosteric ligands (NALs), binding to a receptor's allosteric Moreover, they have the potential to enhance target selectivity, which can arise from greater sequence Allosteric agonists binding to intracellular sites can also promote G-protein signaling.